NCT00918606View on ClinicalTrials.gov

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Subcutaneous Adipose Tissue Reduction

Interventions

DRUG

LIPO-102

LIPO-102

Trial Locations (1)

Unknown

Baltimore

Sponsors

Lead Sponsor

Neothetics, Inc

All Listed Sponsors

lead

Neothetics, Inc

INDUSTRY